AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
AXSOME THERAPEUTICS, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from draw down of debt → financing reconciliation: $70,000,000.00Proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan → financing reconciliation: $41,968,000.00Proceeds from issuance of common stock upon financing → financing reconciliation: $13,474,000.00financing reconciliation → Net cash from financing activities: $48,146,000.00financing reconciliation → Repayment of debt: $70,000,000.00financing reconciliation → Payment of contingent consideration: $3,050,000.00financing reconciliation → Payments of tax withholdings on stock awards: $2,834,000.00financing reconciliation → Payments on principal portion of finance lease obligation: $1,210,000.00financing reconciliation → Cash paid for common stock issuance costs: $202,000.00Net cash used in investing activities → investing reconciliation: $450,000.00investing reconciliation → Purchases of equipment: $450,000.00Net cash used in operating activities → operating reconciliation: $32,952,000.00Accrued expenses and other current liabilities → operating reconciliation: $46,610,000.00Stock-based compensation expense → operating reconciliation: $27,148,000.00Prepaid expenses and other current assets → operating reconciliation: $2,146,000.00Amortization of intangible asset → operating reconciliation: $1,589,000.00Right-of-use asset amortization for finance lease → operating reconciliation: $1,155,000.00Non-cash lease expense → operating reconciliation: $857,000.00Non-current inventory and other assets → operating reconciliation: $855,000.00Amortization of debt discount → operating reconciliation: $164,000.00Depreciation → operating reconciliation: $143,000.00operating reconciliation → Net loss: $51,314,000.00operating reconciliation → Accounts payable: $27,733,000.00operating reconciliation → Accounts receivable, net: $26,397,000.00operating reconciliation → Inventories, net: $5,890,000.00operating reconciliation → Gain in fair value of contingent consideration: $1,496,000.00operating reconciliation → Operating lease liability: $789,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $305,106,000.00Net cash from financing activities → Cash sources and uses: $48,146,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $319,850,000.00Cash sources and uses → Net cash used in investing activities: $450,000.00Cash sources and uses → Net cash used in operating activities: $32,952,000.00Net loss: -$51,314,000.00Net loss−$51.31 MStock-based compensation expense: $27,148,000.00Stock-based compensation+$27.15 MAmortization of intangible asset: $1,589,000.00Intangible amortization+$1.59 MAmortization of debt discount: $164,000.00Discount & premium amortization+$164.00 KLoss on debt extinguishment: $0.00Depreciation: $143,000.00Depreciation expense+$143.00 KGain in fair value of contingent consideration: -$1,496,000.00Contingent consideration FV gain−$1.50 MRight-of-use asset amortization for finance lease: $1,155,000.00Finance lease asset amortization+$1.16 MNon-cash lease expense: $857,000.00Non-cash lease expense+$857.00 KAccounts receivable, net: -$26,397,000.00Accounts receivable−$26.40 MInventories, net: -$5,890,000.00Inventories−$5.89 MNon-current inventory and other assets: $855,000.00Non-current inventory & other+$855.00 KPrepaid expenses and other current assets: $2,146,000.00Prepaid & other current assets+$2.15 MOperating lease liability: -$789,000.00Operating lease liabilities−$789.00 KAccounts payable: -$27,733,000.00Accounts payable−$27.73 MAccrued expenses and other current liabilities: $46,610,000.00Other payables & accruals+$46.61 MNet cash used in operating activities: -$32,952,000.00. Cash required to fund net payments.Operating cash−$32.95 Moperating reconciliation: $113,619,000.00Proceeds from draw down of debt: $70,000,000.00Long-term credit line borrowings+$70.00 MRepayment of debt: -$70,000,000.00Long-term debt repaid−$70.00 MPayments on principal portion of finance lease obligation: -$1,210,000.00Finance lease payments−$1.21 MProceeds from issuance of common stock upon financing: $13,474,000.00Common stock issued+$13.47 MProceeds from issuance of common stock upon exercise of options and under employee stock purchase plan: $41,968,000.00Option & stock plan proceeds+$41.97 MCash paid for common stock issuance costs: -$202,000.00Stock issuance costs−$202.00 KPayment of contingent consideration: -$3,050,000.00Contingent consideration paid−$3.05 MPayments of tax withholdings on stock awards: -$2,834,000.00Stock-award tax withholding−$2.83 MNet cash from financing activities: $48,146,000.00Financing cash+$48.15 Mfinancing reconciliation: $125,442,000.00Purchases of equipment: -$450,000.00PP&E purchases−$450.00 KNet cash used in investing activities: -$450,000.00. Cash required to fund net payments.Investing cash−$450.00 Kinvesting reconciliation: $450,000.00Cash sources and uses: $353,252,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $305,106,000.00Beginning cash$305.11 MEnding cash: Cash, cash equivalents, and restricted cash: $319,850,000.00Ending cash$319.85 MCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsNet loss −$51.31M + net operating adjustments $18.36M = operating cash −$32.95MFree cash flow−$33.40 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$14.74 MEnding cash − beginning cash
Chart details

AXSOME THERAPEUTICS, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
305,106,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 32,952,000 US dollars. Net cash used.
Net loss
negative 51,314,000 US dollars
Stock-based compensation expense
27,148,000 US dollars
Amortization of intangible asset
1,589,000 US dollars
Amortization of debt discount
164,000 US dollars
Loss on debt extinguishment
0 US dollars
Depreciation
143,000 US dollars
Gain in fair value of contingent consideration
negative 1,496,000 US dollars
Right-of-use asset amortization for finance lease
1,155,000 US dollars
Non-cash lease expense
857,000 US dollars
Accounts receivable, net
negative 26,397,000 US dollars
Inventories, net
negative 5,890,000 US dollars
Non-current inventory and other assets
855,000 US dollars
Prepaid expenses and other current assets
2,146,000 US dollars
Operating lease liability
negative 789,000 US dollars
Accounts payable
negative 27,733,000 US dollars
Accrued expenses and other current liabilities
46,610,000 US dollars
Investing activities
negative 450,000 US dollars. Net cash used.
Purchases of equipment
negative 450,000 US dollars
Financing activities
48,146,000 US dollars. Net cash provided.
Proceeds from draw down of debt
70,000,000 US dollars
Repayment of debt
negative 70,000,000 US dollars
Payments on principal portion of finance lease obligation
negative 1,210,000 US dollars
Proceeds from issuance of common stock upon financing
13,474,000 US dollars
Proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan
41,968,000 US dollars
Cash paid for common stock issuance costs
negative 202,000 US dollars
Payment of contingent consideration
negative 3,050,000 US dollars
Payments of tax withholdings on stock awards
negative 2,834,000 US dollars
Operating adjustment reconciliation
113,619,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
125,442,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
450,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
319,850,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
353,252,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
14,744,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
negative 32,952,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
450,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 33,402,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$51.31M + net operating adjustments $18.36M = operating cash −$32.95M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 32,952,000 US dollars minus 450,000 US dollars equals negative 33,402,000 US dollars.
AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!